Drug
Cultured Thymus Tissue For Implantation
Cultured Thymus Tissue For Implantation: highest development phase Phase 1/2, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cultured Thymus Tissue for Implantation (CTTI) NCT00579527 | Phase 1/2 | DiGeorge Anomaly |
Latest
No recent events.
Follow Cultured Thymus Tissue For Implantation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.